Suppr超能文献

南非针对精神病患者的同伴主导康复小组(PRIZE):一项随机对照可行性试验方案

Peer-led recovery groups for people with psychosis in South Africa (PRIZE): protocol for a randomised controlled feasibility trial.

作者信息

Asher Laura, Rapiya Bongwekazi, Repper Julie, Reddy Tarylee, Myers Bronwyn, Hanlon Charlotte, Petersen Inge, Brooke-Sumner Carrie

机构信息

Academic Unit of Lifespan and Population Health, School of Medicine, University of Nottingham, Nottingham, UK.

Alcohol, Tobacco and Other Drug Research Unit, South African Medical Research Council, Francie Van Zijl Drive, Parow Valley, Cape Town, 7501, South Africa.

出版信息

Pilot Feasibility Stud. 2023 Feb 1;9(1):19. doi: 10.1186/s40814-022-01232-8.

Abstract

BACKGROUND

The available care for people with psychosis in South Africa is inadequate to support personal recovery. Group peer support interventions are a promising approach to foster recovery, but little is known about the preferences of service users, or the practical application of this care model, in low- and middle-income countries (LMIC). This study aims to assess the acceptability and feasibility of integrating peer-led recovery groups for people with psychosis and their caregivers in South Africa into existing systems of care, and to determine key parameters in preparation for a definitive trial.

METHODS

The study is set in Nelson Mandela Bay Metropolitan district of the Eastern Cape Province, South Africa. The design is an individually randomised parallel group feasibility trial comparing recovery groups in addition to treatment as usual (TAU) with TAU alone in a 1:1 allocation ratio. We aim to recruit 100 isiXhosa-speaking people with psychosis and 100 linked caregivers. TAU comprises anti-psychotic medication-focused outpatient care. The intervention arm will comprise seven recovery groups, including service users and caregiver participants. Recovery groups will be delivered in two phases: a 2-month phase facilitated by an auxiliary social worker, then a 3-month peer-led phase. We will use mixed methods to evaluate the process and outcomes of the study. Intervention acceptability and feasibility (primary outcomes) will be assessed at 5 months post-intervention start using qualitative data collected from service users, caregivers, and auxiliary social workers, along with quantitative process indicators. Facilitator competence will be assessed with the GroupACT observational rating tool. Trial procedures will be assessed, including recruitment and retention rates, contamination, and validity of quantitative outcome measures. To explore potential effectiveness, quantitative outcome data (functioning, unmet needs, personal recovery, internalised stigma, health service use, medication adherence, and caregiver burden) will be collected at baseline, 2 months, and 5 months post-intervention start.

DISCUSSION

This study will contribute to the sparse evidence on the acceptability and feasibility of peer-led and recovery-oriented interventions for people with psychosis in LMIC when integrated into existing care systems. Results from this feasibility trial will inform preparations for a definitive trial and subsequent larger-scale implementation.

TRIAL REGISTRATION

Pan-African Clinical Trials Register PACTR202202482587686. Registered on 28 February 2022.  https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=21496 .

摘要

背景

在南非,为精神病患者提供的现有护理不足以支持其个人康复。同伴支持小组干预是促进康复的一种有前景的方法,但在低收入和中等收入国家(LMIC),对于服务使用者的偏好以及这种护理模式的实际应用知之甚少。本研究旨在评估在南非将针对精神病患者及其照料者的同伴主导康复小组纳入现有护理系统的可接受性和可行性,并确定为确定性试验做准备的关键参数。

方法

该研究在南非东开普省的纳尔逊·曼德拉湾都会区进行。设计为个体随机平行组可行性试验,以1:1的分配比例比较在常规治疗(TAU)基础上增加康复小组与单纯TAU的效果。我们的目标是招募100名讲科萨语的精神病患者和100名相关照料者。TAU包括以抗精神病药物为重点的门诊护理。干预组将包括七个康复小组,参与者包括服务使用者和照料者。康复小组将分两个阶段进行:由辅助社会工作者推动的为期2个月的阶段,然后是为期3个月的同伴主导阶段。我们将使用混合方法来评估研究的过程和结果。干预的可接受性和可行性(主要结果)将在干预开始后5个月,使用从服务使用者、照料者和辅助社会工作者收集的定性数据以及定量过程指标进行评估。将使用GroupACT观察评分工具评估促进者的能力。将评估试验程序,包括招募和保留率、污染情况以及定量结果测量的有效性。为了探索潜在效果,将在干预开始时的基线、2个月和5个月收集定量结果数据(功能、未满足的需求、个人康复、内化耻辱感、卫生服务利用、药物依从性和照料者负担)。

讨论

本研究将为低收入和中等收入国家将同伴主导和以康复为导向的干预措施纳入现有护理系统时,关于其对精神病患者的可接受性和可行性的稀少证据做出贡献。该可行性试验的结果将为确定性试验及后续更大规模实施的准备工作提供信息。

试验注册

泛非临床试验注册中心PACTR202202482587686。于2022年2月28日注册。https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=21496

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6c4/9890934/d27e89f2b5a7/40814_2022_1232_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验